OPTIMER PHARMACEUTICALS INC Deferred Tax Assets, Valuation Allowance
OPTIMER PHARMACEUTICALS INC had Deferred Tax Assets, Valuation Allowance of $101.85 million as of 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2013-03-18
- 2012-12-31: Deferred Tax Assets, Valuation Allowance $101.85M.
- 2011-12-31: Deferred Tax Assets, Valuation Allowance $88.46M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2012-12-31 | $101.85M 10-K · filed 2013-03-18 |
| 2011-12-31 | $88.46M 10-K · filed 2013-03-18 |